Alnylam Pharmaceuticals | Biaya Penjualan



Cost Of Sales Perubahan Tanggal
Acadia Pharmaceuticals USD 21.8M 2.95M 2024-12
Agios Pharmaceuticals USD 1.26M 477K 2024-12
Alnylam Pharmaceuticals USD 102.82M 16.91M 2024-12
Amgen USD 3.11B 198M 2024-12
BioMarin Pharmaceutical USD 136.14M 52.32M 2024-12
Incyte USD 82.38M 2.49M 2024-12
Ionis Pharmaceuticals USD 3.83M 2.76M 2024-12
Moderna USD 546M 246M 2024-12
Neurocrine Biosciences USD 9.3M 1.3M 2024-12
Novartis USD 3.31B 73M 2024-12
PTC Therapeutics USD 16.28M 5.44M 2024-12
Regeneron Pharmaceuticals USD 565.4M 74.3M 2024-12
Sanofi EUR 4.08B 675M 2024-09
Sarepta Therapeutics USD 132.3M 40.61M 2024-12
Takeda JPY 416.87B 22.56B 2024-12
Ultragenyx Pharmaceutical USD 16.89M 4.13M 2024-12
Vertex Pharmaceuticals USD 423.4M 30.8M 2024-12
Xencor 10.71M 4.56M 2024-09



Alnylam Pharmaceuticals Biaya Penjualan - Nilai saat ini, data historis, perkiraan, statistik, grafik dan kalender ekonomi - Mar 2025.